HBM Healthcare Investments AG

HBM Healthcare Investments publishes Quarterly Report as at 30 June 2024 with key figures for the first three months of the 2024/2025 financial year

HBM portfolio company Yellow Jersey Therapeutics to be acquired for USD 1.25 billion

HBM Healthcare Investments achieves a balanced result in the 2023/2024 financial year

HBM Healthcare Investments publishes net asset value per share (NAV) of CHF 248.10 as at 31 March 2024 and quarterly profit of CHF 156 million

HBM Healthcare Investments publishes Quarterly Report as at 31 December 2023 with key figures for the first nine months of the 2023/2024 financial year

HBM Healthcare Investments publishes net asset value per share (NAV) of CHF 225.03 as at 31 December 2023